Get started
Author

Ana Lacerda

Observed names: A F Lacerda, A F de Lacerda, A. Forjaz De Lacerda, A. Lacerda, Ana Forjaz De Lacerda, Ana Forjaz Lacerda, Ana Forjaz de Lacerda, Forjaz De Lacerda, A., Forjaz De Lacerda, Ana, Lacerda, Ana, Lacerda, Ana Forjaz De
Observed institutions: University of Leicester, Instituto Português de Oncologia de Coimbra Francisco Gentil, King's College London, Universidade Católica Portuguesa, Great Ormond Street Hospital, Ghent University Hospital, Istituto Giannina Gaslini, Institut Gustave Roussy, Ghent University, University of Catania, Instituto Português de Oncologia Francisco Gentil, European Society for Paediatric Oncology, Schneider Children's Medical Center, Royal Marsden Hospital, St Anna Children's Hospital, Hôpital des Enfants, European Association for Palliative Care, Children's Cancer and Leukaemia Group, St. Anna Children's Cancer Research Institute, Institut Curie, Universidade Nova de Lisboa
ORCID: 0000-0003-3387-3521
Observed ORCID: 0000-0003-3387-3521
OpenAlex ID: A5091316172
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial
2017 · Ruth Ladenstein, Ulrike Pötschger, et al. · The Lancet Oncology · 360
International Standards for Pediatric Palliative Care: From IMPaCCT to GO-PPaCS
2022 · Franca Benini, Danai Papadatou, et al. · Journal of Pain and Symptom Management · 324
PDF
Excellent Outcome With Reduced Treatment for Infants With Disseminated Neuroblastoma Without MYCN Gene Amplification
2009 · Bruno De Bernardi, Mary Gerrard, et al. · Journal of Clinical Oncology · 141
Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study
2020 · Keith Holmes, Ulrike Pötschger, et al. · Journal of Clinical Oncology · 136
PDF
Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN Study
2010 · Ruth Ladenstein, Dominique Valteau-Couanet, et al. · Journal of Clinical Oncology · 135
Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group
2008 · B De Bernardi, V Mosseri, et al. · British Journal of Cancer · 132
PDF
Busulphan-melphalan as a myeloablative therapy (MAT) for high-risk neuroblastoma: Results from the HR-NBL1/SIOPEN trial.
2011 · R. L. Ladenstein, U. Poetschger, et al. · Journal of Clinical Oncology · 47
Trends in cause and place of death for children in Portugal (a European country with no Paediatric palliative care) during 1987–2011: a population-based study
2017 · Ana Forjaz de Lacerda, Barbara Gomes · BMC Pediatrics · 40
PDF
Busulphan-melphalan as a myeloablative therapy (MAT) for high-risk neuroblastoma: Results from the HR-NBL1/SIOPEN trial.
2011 · R. L. Ladenstein, U. Poetschger, et al. · Journal of Clinical Oncology · 34
Utilização do Internamento Hospitalar em Portugal Continental por Crianças com Doenças Crónicas Complexas (2011 – 2015)
2019 · Ana Forjaz Lacerda, Graça Oliveira, et al. · Acta Médica Portuguesa · 19
Embracing paediatric palliative care in paediatric oncology from diagnosis onwards
2023 · Ana Lacerda, María Avilés Martínez, et al. · Pediatric Blood & Cancer · 18
PDF
Portugal needs to revolutionise end-of-life care
2020 · Barbara Gomes, Maja de Brito, et al. · The Lancet · 15
PDF
International consensus on sleep problems in pediatric palliative care: Paving the way
2024 · Anna Mercante, Judith Owens, et al. · Sleep Medicine · 13
Perceptions of physicians caring for pediatric patients with cancer in Europe: insights into the use of palliative care, its timing, and barriers to early integration
2024 · Ana Lacerda, Isabel M. Bravo-Carretero, et al. · Frontiers in Oncology · 12
PDF
A call to improve paediatric palliative care quality through research
2023 · Laure Dombrecht, Ana Lacerda, et al. · BMC Palliative Care · 12
PDF
The prognostic value of semi-quantitative 123I MIBG scintigraphy at diagnosis in high risk neuroblastoma: validation of the SIOPEN score method
2011 · Ruth Ladenstein, Ulrike Pöetschger, et al. · Ghent University Academic Bibliography (Ghent University) · 10
The prognostic value of semi-quantitative 123I mIBG scintigraphy at diagnosis in high-risk neuroblastoma: Validation of the SIOPEN score method.
2011 · V. Lewington, U. Poetschger, et al. · Journal of Clinical Oncology · 9
Neuroblastoma in Infants: Long‐Term Survival From INES Protocols A SIOPEN Study
2025 · Julie Savagner, Caroline Munzer, et al. · Pediatric Blood & Cancer · 5
PDF
Aggressiveness of care at the end of life in children with cancer: A nationwide cohort study
2017 · A. Cardoso, D. Martins Branco, et al. · Annals of Oncology · 5
CGH evaluation of two de novo synchronous tumors in a child with a germline p53 mutation
2005 · Lúcia Roque, Ana Lacerda, et al. · Pediatric Blood & Cancer · 5
P73 Expression in Neuroblastoma: a Role in the Biology of Advanced Tumors?
2001 · Paulo Matos, Glória Isidro, et al. · Pediatric Hematology and Oncology · 3
Physicians’ opinions on and practical experiences with palliative sedation therapy in children: an international survey in five European countries
2025 · Hanna Fischer, Deborah Gubler, et al. · BMC Palliative Care · 2
PDF
Aggressiveness of Care at the End of Life of Children Dying with Cancer in Public Hospitals—A Nationwide Retrospective Cohort Study
2024 · Ana Lúcia Cardoso, Luis Guilherme Del Nero, et al. · Journal of Palliative Medicine · 2
Está Aberta a Porta aos Cuidados Paliativos Pediátricos
2018 · Lacerda, Ana Forjaz De · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · 1
PDF
Cuidados Paliativos Para Crianças? Sim, Por Favor!
2016 · Lacerda, Ana Forjaz De · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · 1
Works count: 41
Citation count: 1,484
H-index: 13
I10-index: 16
Year
Topic
Type